A vial of Tirzepatide (10mg), manufactured by PUCA, was submitted by the manufacturer itself for testing and verification. The analysis was both submitted and funded by PUCA, reflecting a proactive quality control measure by the producer. Testing was carried out by Janoshik Analytical, a laboratory recognized for its pharmaceutical and peptide validation services.
The test found a measured content of 10.04 mg and an exceptional purity of 99.289%, indicating that the sample meets and slightly exceeds the labeled specification. This result demonstrates strong adherence to manufacturing accuracy and peptide integrity.
Detailed Report
Product Overview
- Manufacturer: PUCA
- Product Name: Tirzepatide
- Active Ingredient: Tirzepatide
- Labeled Concentration: 10 mg
- Measured Amount: 10.04 mg
- Purity: 99.289%
- Batch Number: 001
- Expiration Date: Not Provided
- Delivery Method: Peptide vial
Sample Acquisition and Testing
- Task Number: #61628
- Testing Ordered: 20 March 2025
- Sample Received: 4 April 2025
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: PUCA (Manufacturer)
- Analysis Paid For By: PUCA (Manufacturer)
Testing Results
| Component/Test | Specification (Label Claim) | Measured Value | Purity |
|---|---|---|---|
| Tirzepatide | 10 mg | 10.04 mg | 99.289% |
Verification Details
- Verification URL: https://janoshik.com/tests/61628_7SKQ1GPF6P93
Evaluation of Manufacturer Testing
The testing of PUCA’s Tirzepatide sample revealed excellent consistency, with a measured amount of 10.04 mg and a 99.289% purity rating, slightly exceeding its 10 mg label. These values are indicative of precise manufacturing practices and high-grade peptide formulation.
As this test was submitted and funded by the manufacturer, it serves as an example of internal quality assurance rather than independent validation. While this does not disqualify the data, third-party submissions tend to carry more weight for assessing market-available batches without bias.
Conclusion
This manufacturer-submitted lab analysis confirms that PUCA’s Tirzepatide 10mg sample delivers the labeled dose with exceptional chemical purity. The results indicate strong product quality and support PUCA’s credibility as a peptide manufacturer.
To enhance consumer trust, such tests should ideally be supplemented by independently submitted samples across multiple batches.
Disclaimer
This report is provided for informational and harm reduction purposes. While the analysis was performed by a trusted lab, the submission by the manufacturer warrants consideration of potential sample selectivity. For thorough evaluation, third-party funded tests across varying production lots are encouraged.
